Videos, webinars, multimedia and publications

Click on the following buttons to access Nordimet® videos, webinars, interviews and publications.

Dawn Homer – Methotrexate auto-injectors for rheumatoid arthritis: patient perceptions and preferences

05:07 – Nordimet (methotrexate) prescribing information and adverse event reporting information can be accessed via the ‘prescribing information’ link at the bottom of the web page below

Patients should receive suitable training and must be told that Nordimet is a once daily treatment. The first dose of Nordimet should be performed under direct medical supervision.

Methotrexate auto-injectors for rheumatoid arthritis: patients’ perceptions and preferences – summary of survey data presented by Dawn Homer, Rheumatology Nurse Consultant at the Modality Partnership, Birmingham, UK

Play Video

Dr Tim Blake – Nordimet® subcutaneous methotrexate auto-injector pen: Insights on clinical and patient experience

04:11 – Nordimet (methotrexate) prescribing information and adverse event reporting information can be accessed via the ‘prescribing information’ link at the bottom of the web page below

Patients should receive suitable training and must be told that Nordimet is a once daily treatment. The first dose of Nordimet should be performed under direct medical supervision.

Consultant Rheumatologist – University Hospital Coventry

Play Video

Parveen Bal – Nordimet® subcutaneous methotrexate auto-injector pen: Insights on clinical and patient experience

07:16 – Nordimet (methotrexate) prescribing information and adverse event reporting information can be accessed via the ‘prescribing information’ link at the bottom of the web page below

Patients should receive suitable training and must be told that Nordimet is a once daily treatment. The first dose of Nordimet should be performed under direct medical supervision.

Clinical Nurse Specialist – University Hospital Coventry

Play Video

Colin Beevor – Nordimet® subcutaneous methotrexate auto-injector pen: Insights on clinical and patient experience

02:37 – Nordimet (methotrexate) prescribing information and adverse event reporting information can be accessed via the ‘prescribing information’ link at the bottom of the web page below

Patients should receive suitable training and must be told that Nordimet is a once daily treatment. The first dose of Nordimet should be performed under direct medical supervision.

Senior Clinical Nurse Specialist – Portsmouth Hospitals NHS Trust

Play Video

Dawn Homer – Nordimet® subcutaneous methotrexate auto-injector pen: Insights on clinical and patient experience

05:36 – Nordimet (methotrexate) prescribing information and adverse event reporting information can be accessed via the ‘prescribing information’ link at the bottom of the web page below

Patients should receive suitable training and must be told that Nordimet is a once daily treatment. The first dose of Nordimet should be performed under direct medical supervision.

Rheumatology Nurse Consultant – Modality Partnership, Birmingham

Play Video

Janet Lartey – Nordimet® subcutaneous methotrexate auto-injector pen: Insights on clinical and patient experience

02:52 – Nordimet (methotrexate) prescribing information and adverse event reporting information can be accessed via the ‘prescribing information’ link at the bottom of the web page below

Patients should receive suitable training and must be told that Nordimet is a once daily treatment. The first dose of Nordimet should be performed under direct medical supervision.

Assistant Advance Rheumatology Nurse Specialist – Wexham Park, Frimley Health Foundation Trust

Play Video

Maggie Thorne – Nordimet® subcutaneous methotrexate auto-injector pen: Insights on clinical and patient experience

04:11 – Nordimet (methotrexate) prescribing information and adverse event reporting information can be accessed via the ‘prescribing information’ link at the bottom of the web page below

Patients should receive suitable training and must be told that Nordimet is a once daily treatment. The first dose of Nordimet should be performed under direct medical supervision.

Rheumatology nurse specialist – University Hospitals of Morecambe Bay

Play Video

Nicky Freeman: Providing Guidance and Empowering Patients, & Past and Present Experiences with Subcutaneous Methotrexate

18:28 – Nordimet (methotrexate) prescribing information and adverse event reporting information can be accessed via the ‘prescribing information’ link at the bottom of the web page below

Patients should receive suitable training and must be told that Nordimet is a once daily treatment. The first dose of Nordimet should be performed under direct medical supervision.

Nicky Freeman (Lead nurse for rheumatology, BWCH & UHCW) provides and overview of the value and importance of empowering JIA patients, and a summary of experience using subcutaneous methotrexate.

Play Video

Supporting patients in Scotland with rheumatic disease (Overview video)

02:30 – Nordimet (methotrexate) prescribing information and adverse event reporting information can be accessed via the ‘prescribing information’ link at the bottom of the web page below

Patients should receive suitable training and must be told that Nordimet is a once daily treatment. The first dose of Nordimet should be performed under direct medical supervision.

Video in which Dr Martin Perry (Rheumatologist & Physician, Specialty Advisor, Clinical Director of Medicine and Honorary Lecturer, University of Glasgow) discusses the optimisation of adherence in rheumatic disease and Genevieve Zabat (Nurse Specialist, NHS Lothian) discusses the role of Nordimet within disease management

Play Video

Supporting patients in Scotland with rheumatic disease (Full video)

38:01 – Nordimet (methotrexate) prescribing information and adverse event reporting information can be accessed via the ‘prescribing information’ link at the bottom of the web page below

Patients should receive suitable training and must be told that Nordimet is a once daily treatment. The first dose of Nordimet should be performed under direct medical supervision.

Video in which Dr Martin Perry (Rheumatologist & Physician, Specialty Advisor, Clinical Director of Medicine and Honorary Lecturer, University of Glasgow) discusses the optimisation of adherence in rheumatic disease and Genevieve Zabat (Nurse Specialist, NHS Lothian) discusses the role of Nordimet within disease management

Play Video

The role of the hospital pharmacist in facilitating patient choice with subcutaneous methotrexate

Nordimet (methotrexate) prescribing information and adverse event reporting information can be accessed via the ‘prescribing information’ link at the bottom of the web page below

Mr Adrian Davies
Directorate Pharmacist, Specialised Medicine, Cardiff and Vale
University Health Board

Open Resource

Patient preference study animation

Nordimet (methotrexate) prescribing information and adverse event reporting information can be accessed via the ‘prescribing information’ link at the bottom of the web page below

Play Video

Sub-cutaneous methotrexate patient preference study infographic

Nordimet (methotrexate) prescribing information and adverse event reporting information can be accessed via the ‘prescribing information’ link at the bottom of the web page below

Open Resource

Caring for JIA patients in a COVID world: responding to a unique set of challenges

Nordimet (methotrexate) prescribing information and adverse event reporting information can be accessed via the ‘prescribing information’ link at the bottom of the web page below

Fiona Brown
Paediatric Rheumatology Nurse Specialist at Noah’s Ark Children’s Hospital for Wales, Cardiff

Open Resource

Adapting rheumatology services for the new COVID reality: Virtual patient management and the use of Nordimet® – Insights from a consultant rheumatologist

Nordimet (methotrexate) prescribing information and adverse event reporting information can be accessed via the ‘prescribing information’ link at the bottom of the web page below

Dr Tim Blake
University Hospitals Coventry and Warwickshire,
NHS Trust, Coventry, UK

Open Resource

Subcutaneous methotrexate (MTX) and the management of rheumatology post-COVID-19 pandemic: Insights from a rheumatology nurse consultant

Nordimet (methotrexate) prescribing information and adverse event reporting information can be accessed via the ‘prescribing information’ link at the bottom of the web page below

Dawn Porter (Homer)
Handsworth Wood Medical Centre (Modality Partnership),
Birmingham, UK

Open Resource

Ask a speaker